Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants
Clinical trial NCT00350272 · COMPLETED
Trial details
- NCT number
- NCT00350272
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-08-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.